SCHEMBL6882402

SCHEMBL6882402

CCOC(=O)N1c2cc(C)c(C)cc2CCC1C

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
HTT P42858 3/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
MAPK1 P28482 1/20 0.41
PDK1 Q15118 9/20 0.40
PDK2 Q15119 9/20 0.40
PDK3 Q15120 9/20 0.40
PDK4 Q16654 9/20 0.40
TSHR P16473 2/20 0.40
LMNA P02545 1/20 0.40
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
HSP90AA1 P07900 2/20 0.37
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7820052 0.86 ALDH1A1 (0.41) ALDH1A1HTTNPC1RAB9AMAPK1
SCHEMBL7826775 0.85 TSHR (0.48) ALDH1A1HTTNPC1RAB9AMAPK1
SCHEMBL7831498 0.80 POLB (0.56) ALDH1A1PDK1PDK2PDK3PDK4
SCHEMBL8779604 0.77 AKR1C3 (0.39) ALDH1A1TSHRMEN1KMT2A
SCHEMBL7397668 0.77 AKR1C3 (0.39) ALDH1A1TSHRMEN1KMT2A
SCHEMBL18871831 0.68 PDK1 (0.49) ALDH1A1HTTNPC1RAB9AMAPK1
SCHEMBL8742789 0.68 MTNR1A (0.48) ALDH1A1HTTTSHRLMNAMEN1
SCHEMBL7305955 0.68 MTNR1A (0.48) ALDH1A1HTTTSHRLMNAMEN1
SCHEMBL15187564 0.68 NOTUM (0.65) ALDH1A1NPC1RAB9AMAPK1TSHR
SCHEMBL7316234 0.67 MTNR1A (0.47) ALDH1A1HTTTSHRLMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1404302-A1 PHARMACEUTICAL COMPOSITIONS OF ADSORBATES OF AMORPHOUS DRUG Pfizer Products Inc. (US) 2004-04-07 EP disclosed
WO-2003000238-A1 PHARMACEUTICAL COMPOSITIONS OF ADSORBATES OF AMORPHOUS DRUG PFIZER PRODUCTS INC. (US) 2003-01-03 WO disclosed